Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Preventive vaccination for viral hepatitis]

W Jilg1

  • 1Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg.

Zeitschrift Fur Gastroenterologie
|July 1, 1997
PubMed
Summary

Viral hepatitis A-E are significant global infectious diseases. Immunoprophylaxis, including passive and active immunization, is crucial for hepatitis A and B due to limited treatments for chronic hepatitis B and C.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time course of hepatitis E-specific antibodies in adults.

Journal of viral hepatitis·2016
Same author

Foodborne hepatitis A outbreak associated with bakery products in northern Germany, 2012.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2015
Same author

[Not Available].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2014
Same author

[Influenza].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.

Infection·2011
Same author

[Vaccinations].

Deutsche medizinische Wochenschrift (1946)·2011

Area of Science:

  • Virology
  • Immunology
  • Public Health

Context:

  • Viral hepatitis A-E are major global infectious diseases, endemic in developing nations and posing risks in industrialized countries like Germany.
  • Germany faces significant annual infections of hepatitis A, B, and C, with substantial chronic carrier populations for B and C.

Purpose:

  • To highlight the importance of immunoprophylaxis for viral hepatitis, particularly given limited therapeutic options for chronic hepatitis B and C.
  • To detail the available immunization strategies for hepatitis A and B, including passive, active, and combined passive-active approaches.

Summary:

  • Passive immunization offers rapid but short-term protection against hepatitis A and B, while active immunization provides delayed but long-lasting immunity.
  • Hepatitis C currently lacks both therapeutic interventions and specific immunoprophylaxis, underscoring a critical gap in prevention and treatment.

Impact:

  • Emphasizes the critical role of vaccination and immunoglobulins in managing and preventing viral hepatitis infections.
  • Highlights the need for further research and development of effective strategies for hepatitis C prevention and treatment.

Related Experiment Videos